Advancing radiotherapeutics to treat solid tumors
Akiram Therapeutics has raised $6.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2022.
Akiram Therapeutics's investors include Sciety.
Akiram Therapeutics is headquartered in Uppsala, Sweden.
Advancing radiotherapeutics to treat solid tumors
Akiram Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akiram Therapeutics — Funding & Investors." VCBacked, November 22, 2022, https://www.vcbacked.co/company/akiram-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Akiram Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/akiram-therapeutics
{{cite web |title=Akiram Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/akiram-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated